Not on air · 3 of 3 networks checked
Seegene Inc.
- seegene.com
- KR
- 511 employees
Seegene Inc.’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 48. Watch Seegene Inc. with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| None recorded | 0 | Checked 30 Oct 2026 | See all 48 ads → | ||
| Meta | None recorded | 0 | No active ads recorded on the Meta Ad Library | Checked 25 Oct 2026 | Collect them with the API → |
| Recently | 2 | Ads on the Google Ads Transparency Center | Checked 16 Oct 2026 | Collect them with the API → |
Seegene Inc. has no live LinkedIn ads. Its Facebook page had no active ads on 25 Oct 2026, and we recorded 2 Google ads on 16 Oct 2026.
Latest ads
- LINKEDIN · IMAGESince 28 Oct 2026
Seegene’s early innovations laid the groundwork for its proprietary molecular diagnostic technologies. In 2001, we developed ACP™ (Annealing Control Primer), a primer designed to improve the specificity of PCR amplification. In 2002, we applied ACP™ in GeneFishing™, a kit for identifying differentially expressed genes (DEGs) across two or more nucleic acid samples. These milestones marked the beginning of Seegene’s journey from primer technology to practical research tools, laying the foundation for future innovation. Read more about Seegene’s history: https://lnkd.in/gsBrAHZ2 #Seegene #ACP #GeneFishing #MolecularDiagnostics #CompanyHistory #PCR
- LINKEDIN · IMAGESince 28 Oct 2026
Our vision for the future of molecular diagnostics is featured in the Los Angeles Times Korea Special Report in an article titled “Diagnostics Without Blind Spots.” In the article, our founder and CEO Dr. Jong-Yoon Chun shares his vision for advancing comprehensive PCR testing, highlighting our laboratory automation, and Technology-Sharing Business. These initiatives reflect our ongoing commitment to generating clinical evidence, expanding access to comprehensive diagnostics, and driving innovation in molecular diagnostics worldwide. Read the full feature here: https://lnkd.in/gRkR_NU3 #LosAngelesTimes #LATimes #MultiplexPCR
- LINKEDIN · IMAGESince 13 Oct 2026
🔬 Broader Detection, Smarter Workflows. Discover Seegene at #LMCE2026. From October 21-23, #Seegene will join laboratory medicine professionals in Seoul to showcase our comprehensive molecular diagnostic solutions and share the latest insights into respiratory testing. Visit us at Booth #04 to explore how STARlet-AIOS™ brings multiple MDx assays together in one streamlined automation system, supporting more efficient laboratory workflows. We will also host a symposium on “The New Generation of Multiplex Respiratory Panels: Clinical Evaluation and Early Experience with Viral and Bacterial Detection,” featuring Dr. Ninad Mehta, who will share clinical insights into comprehensive respiratory diagnostics. We look forward to connecting with you at #LMCE2026! 📍 Booth #04, Grand Walkerhill, Seoul, Korea 📅 October 21–23, 2026 🎤 Symposium October 22 | 11:30 AM–12:30 PM | Room B (EW 06) ▶ Learn more here: lmce-kslm.org/ #LMCE #MolecularDiagnostics #MultiplexPCR #LaboratoryMedicine #STARletAIOS
- LINKEDIN · IMAGESince 21 Sept 2026
🇫🇷 Chers amis français, Seegene France est désormais en ligne. Suite à la création de notre filiale française l’année dernière, nous sommes ravis de lancer le site web de Seegene France. Conçu pour rapprocher Seegene de ses clients et partenaires en France, ce site web facilite l’accès à nos solutions et technologies, ainsi qu’aux actualités locales, aux informations sur nos produits et à diverses ressources. Nous prévoyons de lancer progressivement des sites web localisés pour d’autres filiales, afin de faciliter la communication où que vous soyez ! 🌐 Découvrez le nouveau site web de Seegene France : fr.seegene.com #Seegene #SeegeneFrance #DiagnosticMoléculaire #PCR #RéseauMondial
- LINKEDIN · IMAGESince 17 Sept 2026
🔬 #ESCV2026 is underway in Porto! It’s been a great start as we welcome the global virology community to #Seegene at booth #B5, connecting with experts and exchanging insights on the evolving landscape of clinical virology and molecular diagnostics. From broader target coverage to deeper insights, visitors are discovering Seegene’s comprehensive approach to molecular diagnostics and what lies beyond detection. 📍 Booth #B5, Super Bock Arena, Porto, Portugal 📅 September 16–19, 2026 ▶ Learn more here: escv2026.org #ESCV #Seegene #MolecularDiagnostics #ClinicalVirology #PCR #InfectiousDiseases #GlobalHealth
- LINKEDIN · IMAGESince 15 Sept 2026
🎂 Celebrating 26 years of Seegene Every journey starts with a vision. Ours began in 2000, with a clear focus on innovating molecular diagnostics. Spun out of the Institute of Life Sciences at Ewha Women’s University, we set out to build our own proprietary technologies — a choice that continues to shape every platform we develop today. 26 years later, the picture looks a lot bigger than that first sketch. Behind every step forward are the people who have dedicated their passion and expertise to building Seegene along the way. Take a look at the story behind Seegene’s 26 years: https://lnkd.in/gsBrAHZ2 #Seegene #26thAnniversary #MolecularDiagnostics #HighMultiplexPCR
6 of 48 adsSign up to see every Seegene Inc. ad, filter by format and date, and get alerts on new ones.
See all 48 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.